share_log

西点药业(301130.SZ):抗病毒片获得药品补充申请批准通知书

West Point Pharmaceutical (301130.SZ): Antiviral tablets have received the approved notice for the supplementary application of the Pharmaceutical.

Gelonghui Finance ·  Mar 17 07:45

Glory Exchange March 17丨West Point Pharmaceutical (301130.SZ) announced that the company recently received the "Drug Supplement Application Approval Notice" issued by the National Medical Products Administration (hereinafter referred to as the "National Drug Administration") for the antiviral tablet. The ingredients of the antiviral tablet include Banlan root, gypsum, rehmannia, patchouli, forsythia, reed root, turmeric, acorus calamus, and anemarrhena. This product has the effects of clearing heat, eliminating dampness, cooling blood, and detoxifying. It is mainly used to treat wind-heat colds, upper respiratory infections, and influenza.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Comment Comment · Views 309

Recommended

Write a comment

Statement

This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.